Scribd Logo
Upload

Welcome to Scribd!

  • Rubin NOHAinTNBC Study Flier Version Date 06.26.2018

    Uploaded by

    kattey
    1K views1 page
    This study aims to determine if a blood test called NOHA can predict how patients with triple negative breast cancer will respond to chemotherapy by testing blood samples from patients before, during, and after chemotherapy treatment. The study seeks volunteers who have been diagnosed with triple negative breast cancer and scheduled for chemotherapy before surgery to provide five blood samples total over the course of their treatment. Participation does not provide direct benefits but could help advance the use of NOHA testing to monitor triple negative breast cancer.

    Original Description:

    Rubin NOHAinTNBC Study Flier Version Date 06.26.2018

    Copyright

    © © All Rights Reserved

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This study aims to determine if a blood test called NOHA can predict how patients with triple negative breast cancer will respond to chemotherapy by testing blood samples from patients before, during, and after chemotherapy treatment. The study seeks volunteers who have been diagnosed with triple negative breast cancer and scheduled for chemotherapy before surgery to provide five blood samples total over the course of their treatment. Participation does not provide direct benefits but could help advance the use of NOHA testing to monitor triple negative breast cancer.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    1K views1 page

    Rubin NOHAinTNBC Study Flier Version Date 06.26.2018

    Uploaded by

    kattey
    This study aims to determine if a blood test called NOHA can predict how patients with triple negative breast cancer will respond to chemotherapy by testing blood samples from patients before, during, and after chemotherapy treatment. The study seeks volunteers who have been diagnosed with triple negative breast cancer and scheduled for chemotherapy before surgery to provide five blood samples total over the course of their treatment. Participation does not provide direct benefits but could help advance the use of NOHA testing to monitor triple negative breast cancer.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Triple Negative Breast Cancer Biomarker Study

    What is the study?


    The study is being done to see if a certain type of blood test (NOHA) is helpful in
    predicting how a person will respond to certain types of chemotherapy.

    Who are we looking for?


    The study is looking for any patient diagnosed with Triple Negative Breast Cancer
    who is scheduled to receive chemotherapy before surgery.

    What do we need from you?


    We will ask you to provide 5 samples of blood at different points: before, during
    and after your chemotherapy. We will also ask your permission to review your
    health records for a maximum of 2 years.

    Why would you participate?


    You will not be paid for participation and there is no cost to you. There will be no
    direct benefit to you, but your contribution could help investigators test the
    usefulness of NOHA as a blood test to monitor Triple Negative Breast Cancer.

    Who is conducting the study?


    Peter Rubin, MD will oversee the study at SMHC.

    The study is looking for volunteers - are you interested in learning


    more?

    Ask your physician or contact:


    Divya Guthikonda, Research Coordinator
    Phone: 207-396-8137

    You might also like